Title : Higher expression of miR-133b is associated with better efficacy of erlotinib as the second or third line in non-small cell lung cancer patients.

Pub. Date : 2018

PMID : 29689091






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Higher expression of miR-133b is associated with better efficacy of erlotinib as the second or third line in non-small cell lung cancer patients. Erlotinib Hydrochloride microRNA 133b Homo sapiens
2 We found that miR-133b expression level better discriminated responder from non-responder patients to erlotinib. Erlotinib Hydrochloride microRNA 133b Homo sapiens
3 The detection of miR-133b expression levels in tumors help in the identification of NSCLC patients with a better prognosis and who are likely to benefit from second and third-line therapy with erlotinib. Erlotinib Hydrochloride microRNA 133b Homo sapiens